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A Review of the Antidiabetic 
Activities of Ginger
Gloria Aderonke Otunola and Anthony Jide Afolayan
Abstract
Diabetes mellitus, a chronic metabolic disorder with major health care burden 
worldwide, is increasing, with 173 million adults being diabetic and over 8 million 
deaths recorded annually. Undesirable pathological conditions and high rates of 
secondary failure limit the use of current antidiabetic agents, thus, the need for 
more effective antidiabetic agents. Medicinal plants such as spices, rich in bioactive 
components that promote prevention and treatment of chronic conditions such 
as heart disease, cancer and Type-2 diabetes, are inexpensive with no side effects. 
The Zingiberaceae family, of which ginger is a member, consists of many species 
frequently cited for their antidiabetic and hypoglycemic properties. All important 
scientific literatures from 2000 to 2018 on the antidiabetic potentials of Zingiber 
officinale were evaluated. According to these studies, ginger exerts its antidiabetic 
effects through restorative effects on pancreatic β-cells, increasing insulin sen-
sitivity, action and peripheral utilization of glucose. Other mechanisms include 
increased synthesis of hepatic glycogen through the enhancement of glycogen 
regulatory enzyme expression in the liver, inhibition of carbohydrate metabolizing 
enzymes, stimulation of pancreatic insulin release and inhibition of hepatic glucose 
production. Further studies, especially in humans are needed, more so, since ginger 
is one of the spices generally regarded as safe.
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1. Introduction
Diabetes mellitus (DM) is the most common endocrine disorder that affects 
more than 100 million people worldwide. It is a heterogeneous group of diseases, 
all of which ultimately lead to an elevation of glucose in the blood (hyperglycemia) 
and loss of glucose in the urine as hyperglycemia increases. It is characterized by 
increased urine production (polyurea) excessive thirst (polydipsia) and excessive 
eating (polyphagia).
Diabetes mellitus is a chronic metabolic disorder of the endocrine system that 
is characterized by defects in impaired metabolism of glucose, lipid and protein as 
well as insulin secretion or insufficiency. Diabetes continues to be a major health 
care problem worldwide and its prevalence is expected to rise from the current 
382–471 million individuals by 2035 [1, 2]. There are three main types of diabetes-
Type 1 diabetes (T1D), which is an autoimmune disorder leading to the destruction of 
pancreatic beta-cells; Type 2 diabetes (T2D), which is much more common and pri-
marily caused by impaired glucose regulation due to a combination of dysfunctional 
pancreatic beta cells and insulin resistance and gestational diabetes mellitus (GDM).
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Different treatments, such as insulin, pharmacotherapy and diet therapies, 
which exert antidiabetic effects through different mechanisms, are currently used 
for the management of diabetes. Such mechanisms include stimulation of insulin 
secretion by sulfonylurea and meglitinides drugs, increase of peripheral absorption 
of glucose by biguanides and thiazolidinediones, delay in the absorption of carbo-
hydrates from the intestine by alpha-glucosidase and reduction of hepatic gluconeo-
genesis by biguanides [3–5].
In spite of the appreciable progress that has been made in the management of 
diabetes through the use of conventional drugs and management strategies, diabe-
tes and its complications continue to be a major medical problem and rising burden 
of disease. Most synthetic oral hypoglycemic agents available for the treatment of 
the disease have some disadvantages, including drug resistance, serious side effects, 
cannot be used during pregnancy, are toxic and also costly [6, 7].
Spices and herbs have played important roles in civilization and history of many 
nations of the world. Their flavor and pungency makes them indispensable in the 
preparation of palatable dishes; but beyond adding flavor, spices are reputed to 
possess several medicinal and pharmacological properties and hence find use in the 
preparation of a number of medicines. Spices can be the dried leaf (e.g., bay leaf), 
buds (cloves), bark (cinnamon), rhizome/root (ginger), berries (grains of pepper), 
seeds (cumin), or even the stigma of the flower (saffron) [8].
The Zingiberaceae plant family consists of many species used as culinary herbs 
and spices, frequently cited for their antidiabetic and hypoglycemic properties. 
Ginger (Zingiber officinale) belongs to this family, and has a long and wide history 
of usage both as a culinary spice and in traditional/alternative medicine. This study 
attempts to update the available scientific information on the antidiabetic and 
hypoglycemic potentials of ginger.
2. Methodology
Online published articles from Google Scholar, ScienceDirect, Scopus, 
ResearchGate, PubMed and SciELO were explored for data collection. For literature 
search, key words such as spices, diabetes, Zingiberaceae, ginger, in vivo, in vitro, 
pharmacological, medicinal, hypoglycemic and antidiabetic were used. The study 
reviewed all important literature from 2000 to 2018.
3. Results
The following sections describe various studies reporting the hypoglycemic and 
antidiabetic properties of ginger, phytochemical constituents responsible for these 
properties and its mechanisms of action.
3.1 Ginger (Zingiber officinale Roscoe)
The ginger (Zingiberaceae) family consists of 53 genera and over 1200 medici-
nal plants, typically tropical annuals or perennials, often with large rhizomes. 
This plant family is well-known for its medicinal values and is distributed widely 
throughout the tropics, particularly in Southeast Asia.
Ginger (Figure 1) has been used for thousands of years for the treatment of 
numerous ailments, such as colds, nausea, arthritis, migraines and hypertension. 
Several authors have reviewed the medicinal, chemical, and pharmacological 
properties of ginger [9–13]. Ginger is recognized by the U.S. Food and Drug 
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Administration (FDA) as a food additive that is “generally recognized as safe” [14] 
and has a long history of use as a culinary spice and in herbal medicine to treat 
many ailments.
Ginger helps to relieve various inflammatory disorders like gout, osteoarthritis 
and rheumatoid arthritis; as an analgesic, hypoglycemic, cardiotonic, antiemetic, 
antimicrobial and antifungal. Other uses include as an antidiabetic, antidyslipid-
emia, hypotensive, vasodilator, antiobesity and anticancer agent [15–18].
In addition, the spice has shown prominent protective effects on diabetic liver, 
kidney, eye, and neural system complications [19]. Several experimental studies 
have reported that administration of ginger extracts significantly decreased blood 
glucose level in Type 1- and Type 2-induced diabetic animals in a dose-dependent 
pattern [20–27].
3.2 Antidiabetic properties of ginger
Lamuchi-Deli et al. [29] evaluated the effects of the hydroalcoholic extract of 
Zingiber officinale on arginase I activity and expression in the retina of strepto-
zotocin-induced diabetic rats. The study showed that blood glucose concentration 
was significantly decreased, arginase I activity and expression was significantly 
(P < 0.05) down regulated and 400 mg/kg of the extract reduced significant 
elevation in body weight in diabetic rats compared to untreated diabetic controls 
(P < 0.01). Serum insulin was also significantly increased in diabetic rats treated 
with 400 mg/kg of the extract compared to diabetic controls (P < 0.05). The study 
suggested that ginger could be a promising therapeutic option for treating diabetes-
induced vascular disorders.
A recent study by de Las Heras et al. [30] which evaluated the hypolipidemic-
and insulin sensitizing effects of hydroethanolic extract of ginger in the liver of 
high-fat diet (HFD) fed rats, revealed that ginger extract improved lipid profile 
and attenuated the increase of plasma levels of glucose, insulin, and leptin in 
HFD rats. Wei et al. [31], also reported that 6-Paradol and 6-Shogaol, the pungent 
compounds of ginger, promoted glucose utilization in adipocytes and myotubes, 
Figure 1. 
Zingiber officinale (ginger) rhizomes. Source: www.amazon.com/Culinary-Ginger-Zingiber-Officinalecooking/
dp/B01NAJQ6C6 [28].
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and 6-paradol reduced blood glucose in HFD-fed mice. Al-Qudah et al. [32] 
reported that aqueous extract of ginger was effective in lowering serum glucose, 
restoration of hematological indices to normal and repair damaged pancreas in 
alloxan-induced diabetic rats.
In another study, Oludoyin and Adegoke [33] investigated the effect of ginger 
extracts on blood glucose in normal and streptozotocin-induced diabetic rats. 
The authors reported that the fasting blood glucose in diabetic rats was reduced to 
normal by both raw and cooked ginger extracts in a manner comparable to gliben-
clamide. Evaluation of the nutritional and antidiabetic activity of ginger powder, 
its aqueous and methanolic extract, as well as the essential oil in streptozotocin-
induced diabetic rats [34] revealed reduction in levels of alanine and aspartate 
aminotransferase (ALT and AST), alkaline phosphatase (ALP), liver total lipid and 
cholesterol of diabetic rats; and increased levels of liver glycogen and triglyceride 
compared to positive control group. In the study, ginger oil showed the best anti-
diabetic activity, followed by ginger extracts. Again, another study reported that 
ginger extract administered at 200 mg/kg/day/kg body weight for 10 weeks to male 
Sprague-Dawley diabetic rats, exhibited protective activity against insulin resis-
tance [34].
Al-Noory et al. [35] showed that fresh ginger extracts led to decrease in the 
levels of total cholesterol (TC) and low density lipoprotein (LDL) in the serum 
of alloxan-induced diabetic rats, compared with the control groups; and previous 
extracts caused reduction in LDL to levels comparable to normal group and equal 
to the effect of atorvastatin given at a dosage of 10 mg/day. Similarly, oral admin-
istration of aqueous ginger extract to streptozotocin (STZ)-induced diabetic rats 
for a period of 30 days was reported to give a dose-dependent antihyperglycemic 
effect, 68% decrease in plasma glucose level at a daily dose of 500 mg/kg body 
weight, indicating that ginger is a potential phytomedicine for the treatment of 
diabetes [36]. Iranloye et al. [37] also showed that ginger effectively reduced fasting 
blood glucose, malondialdehyde levels and enhanced insulin sensitivity in alloxan-
induced and insulin-resistant diabetic rats compared to control rats.
Treatment of streptozotocin-induced Type I diabetic rats with Z. officinale juice 
(4 mL kg−1, p.o. daily for 6 weeks) was reported to produce a significant increase 
in insulin levels, decrease in fasting glucose levels, as well as significant decrease in 
the area under the curve of glucose in an oral glucose tolerance test [38]. According 
to Nammi et al. [23], treatment with an ethanolic extract of ginger at doses of 100, 
200, and 400 mg/kg for 6 weeks, significantly reduced the marked increase in body 
weight, serum glucose, insulin, total cholesterol, LDL cholesterol, triglycerides, free 
fatty acid and phospholipids induced by high-fat diet.
The study conducted by Al-Amin et al. [39] on the antidiabetic and hypolipid-
emic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic 
rats revealed that raw ginger at a dose of 500 mg/kg, was significantly effective in 
lowering serum glucose, cholesterol and triacylglycerol as well as reduction in urine 
protein (reversal of diabetic proteinuria) levels, of diabetic rats. Ethanolic extracts 
of Zingiber officinale (200 mg/kg) given orally for 20 days was reported to produce 
significant antihyperglycemic effect (P < 0.01) in diabetic rats, while also lowering 
serum total cholesterol and triglycerides, coupled with increased HDL-cholesterol 
levels when compared with pathogenic diabetic rats [40].
Hypoglycemic effect of ginger (4 and 8 g/kg), administered intraperitoneally to 
rats after 30 min of diabetes induction, with the effect being more pronounced after 
2 h has been reported. In another study, Otunola and Afolayan [41], showed that 
aqueous extract of a spice mixture containing ginger at 500 mg/kg body weight extract 
significantly (p < 0.05) lowered the elevated fasting blood glucose, lipid and hemato-
logical indices of alloxan-induced diabetic rats at equipotent level with glibenclamide.
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Several in vitro hypoglycemic potentials of ginger and its bioactive constituents 
especially 6-shogaol have been reported (Table 1).
The capacity of ginger for hypoglycemic, antidiabetic, insulogenic, better 
glucose tolerance, increased serum insulin levels, reduction in elevated lipid levels, 
and prevention of weight loss associated with diabetes in human diabetic patients 
have also been reported (Table 2).
3.3 Phytochemical components of Zingiber officinale
GC-MS profiling of diethyl extracts as reported by Koch et al. [46] showed 
the presence of monoterpenes such as (α-pinene, camphene, myrcene, and 
α-phellandrene), oxygenated monoterpenes (geranial, citronellal, neral, linalool, 
borneol, and α-terpineol), and sesquiterpenes (α-and β-farnesene, ar-curcumene, 
zingiberene, zingiberenol, copaene, or cadinene). The most abundant substances in 
the extracts were α-zingiberene (37.9%), β-sesquiphellandrene (11.4%), (E,E)-α-
farnesene (9.6%), geranial (8.2%), ar-curcumene (6.3%), and γ-terpinene (5.1%).
Similarly, Sharma et al. [47] reported that the essential oil of fresh ginger rhi-
zome was characterized by high percentage of sesquiterpenes (66.66%), monoter-
penes (17.28%) and aliphatic compounds (13.58%). The predominant sesquiterpene 
was zingiberene (46.71%) followed by valencene (7.61%), β-funebrene (3.09%) and 
selina-4(14),7(11)-diene (1.03%).
3.4 Mechanism of action
Various mechanisms have been proposed for the antidiabetic and hypoglycemic 
activities of medicinal plants. These include peripheral utilization of glucose, 
increased synthesis of hepatic glycogen by enhancement of glycogen regulatory 
enzyme expression in the liver, inhibition of carbohydrate metabolizing enzymes, 
stimulation of pancreatic insulin release, insulomimetic actions and inhibition of 
hepatic glucose production [55, 56].
According to Dearlove et al. [57], spices such as cinnamon, cloves, oregano, 
and allspice possess bioactive compounds that have (1) antiglycation properties 
which inhibit the formation of AGEs; (2) antioxidant activities that neutralize the 
In vitro study Result/outcome References
[6]-Gingerol on 3 T3-L1 cells Enhanced differentiation of 3T3-L1 preadipocytes and 
insulin-sensitive glucose uptake
Sekiya et al. [42]
[6]-Shogaol or [6]-gingerol 
on 3 T3-L1 cells
Significant inhibition of TNF-α-mediated adiponectin 
expression in 3T3-L1 adipocytes.
[6]-Shogaol acted as a peroxisome proliferator-
activated receptor (PPAR)γ agonist, while [6]-gingerol 
acted by suppressing TNF-α-induced JNKs signaling
Isa et al. [43]
Ethyl acetate extract of 
ginger on L6 myotube cell 
surface
Stimulated glucose uptake and GLUT4 expression in 
L6 myotube cell surface, reduced lipid content in 3T3 
adipocyte, and inhibited protein glycation.
Inhibited α-amylase (IC50 = 980.2 μg/mL) and 
α-glucosidase (IC50 = 180.1 μg/mL)
Rani et al., [44]
Aqueous extract of ginger at 
5, 10, 20, 40 g/L incubated 
with (PBS), glucose + BSA 
for 5 weeks
Dose-dependent, antidiabetic activity through 
inhibition of glucose diffusion and reduced glycation
Sattar et al., [45]
Table 1. 
In vitro hypoglycemic potentials of ginger and its bioactive constituents.
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effects of ROS; and (3) anti-inflammatory potentials. Some studies associate the 
antidiabetic action of ginger to its bioactive principles such as gingerol and shogaol 
which have the capacity to enhance glucose uptake in rat’s skeletal muscle cells, and 
promote increased expression and translocation of GLUT-4 glucose transporter to 
the plasma membrane of the cells thus clearing excess glucose from the serum [34].
Another mechanism proposed was the inhibition of key enzymes of carbohy-
drate metabolism-α-glucosidase and α-amylase by phenolic compounds (gingerols 
and shogaols) present in ginger [23, 45]; while other authors showed that ginger 
increases muscle and liver glycogen stores by enhancing peripheral utilization of 
glucose, thus limiting gluconeogenesis in the liver and kidney in a manner similar to 
insulin [37].
Son et al. [58], posits that-gingerol exerts its antidiabetic effects through 
multiple mechanisms that include—(1) increased glucose uptake in the absence 
Human trials/dosage Results References
Type 2 diabetic men (40–60 years) 
given 3 g/day of dry ginger powder in 
divided doses for 30 days. Number-8 
T2D, 8 placebo
Significant reduction of blood glucose, 
triglyceride, total cholesterol, LDL and 
VLDL cholesterol
Andallu et al. [48]
Randomized double-blind placebo-
controlled trial, patients with Type 
2 diabetes, given 2 g/day of ginger 
extract supplementation. Number-28 
T2D, 30 Placebo
Significantly lowered levels of 
insulin, LDL-C, TG, HOMA index 
and increased the QUICKI index; no 
significant changes in FPG, TC, HDL-C 
and HbA1c; improved insulin sensitivity
Mahluji et al. [49]
Randomized controlled trial of 
Type 2 diabetic men between 30 and 
70 years given 1.6 g/day of ginger 
or wheat flour capsule. Number-33 
T2D, 30 Placebo
Decreased fasting blood glucose, 
glycosylated hemoglobin, fasting 
insulin, homeostasis model assessment-
insulin resistance index, total 
cholesterol and triglyceride. No change 
in BMI, LDL-C, LDL-C and HDL-C
Arablou et al. [50]
Randomized controlled trial of Type 
2 diabetic patients (30–70 years) 
given either 3 g/day ginger or 
cellulose microcrystalline capsules for 
8 weeks. Number-40 T2D, 41Placebo
Significant reduction in fasting blood 
glucose and glycosylated hemoglobin; 
no change in BMI, fasting insulin and 
homeostasis model assessment-insulin 
resistance index
Mozaffari-Khosravi 
et al. [51]
Randomized, double-blind, placebo-
controlled, clinical trial where Type 2 
diabetic patients received 2 g/day of 
ginger powder supplement or lactose 
as placebo for 12 weeks. Number-22 
T2D, 19 placebo
Significant reduction of fasting blood 
sugar, hemoglobin A1c, apolipoprotein 
B, apolipoprotein B/apolipoprotein 
A-I and malondialdehyde in ginger 
group compared to baseline and control 
group, while increasing apolipoprotein 
A-I in Type 2 diabetic patients
Khandouzi et al. [52]
Randomized controlled trial of Type 
2 diabetic patients (20–60 y) T2DM 
given 3 g ginger or lactose capsule/
day for 3 months. Number-22 T2D, 
23 Placebo
Reduced fasting blood glucose, 
glycosylated hemoglobin, fasting 
insulin, homeostasis model assessment-
insulin resistance index
Shidfar et al. [53]
Double-blind placebo-controlled 
trials of Type 2 diabetic patients were 
randomly allocated to 2000 mg/day 
of ginger or placebo for 10 weeks. 
Number-25 T2D, 25 placebo
Reduced serum levels of fasting blood 
glucose, hemoglobin A1C compared to 
placebo group, reduced ratio of LDL-C/
HDL-C; but no significant change in 
serum concentrations of triglycerides, 
total cholesterol, LDL-C, and HDL-C
Arzatii et al. [54]
Table 2. 
Clinical (human) trials of the antidiabetic potentials of ginger.
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of insulin, (2) induction of 5′ adenosine monophosphate-activated protein kinase 
phosphorylation, (3) promotion of glucose transporter 4 (GLUT4) translocation to 
plasma membrane, (4) suppression of advanced glycation end product-induced rise 
of ROS levels in pancreatic β-cells, (5) reduction of fasting blood glucose levels and 
improved glucose intolerance, (6) regulation of hepatic gene expression of enzymes 
involved in glucose metabolism toward decreased gluconeogenesis and glycogenoly-
sis, while increasing glycogenesis, thereby reducing blood glucose concentrations.
4. Conclusion
This study presented an update on the antidiabetic potentials of ginger from 
the Zingiberaceae family. Although several in vivo and in vitro reports were avail-
able, there were relatively few clinical (human) trials. The doses and outcomes also 
varied; as well as the mechanism of action through which antidiabetic effects were 
mediated. Although these reports are indicative of the anti-diabetic or hypoglyce-
mic potentials of ginger, the doses and outcomes also varied; most importantly, the 
mechanisms of action through which anti-diabetic effects are mediated were high-
lighted. Ginger, according to these studies, exerts its anti-diabetic effects through 
restorative effects on pancreatic β-cells, increasing insulin sensitivity, insulin-like 
action and peripheral utilization of glucose. Other mechanisms include increased 
synthesis of hepatic glycogen through the enhancement of glycogen regulatory 
enzyme expression in the liver, inhibition of carbohydrate metabolizing enzymes, 
stimulation of pancreatic insulin release, and inhibition of hepatic glucose produc-
tion. However, further studies, especially in humans are therefore needed and the 
oral safety of the various extracts under prolonged usage must be confirmed, more 
so, since ginger is one of the spices generally regarded as safe.
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